Quest -Model LacriCATH -Balloon Catheters

SHARE

Quest’s LacriCATH balloon catheters have revolutionized the treatment of blocked tear ducts (chronic epiphora and nasolacrimal duct obstruction) in children and adults.

Most popular related searches

Chronic tearing and blocked lacrimal duct treatments using LacriCATH balloon catheters are less invasive and less traumatic for the patient. Available in sizes and styles for both Dacryoplasty (DCP) and Dacryocystorhinostomy (DCR) procedures, LacriCATH balloon catheters offer patients seeking an epiphora treatment a simple and effective alternative to incisional surgery.

Sterile kits are available in unilateral (UNIT) or bilateral (BIT) and are single-use.

UNIT kits include catheter(s), an inflation device, BIT kits include 4-way stocpcock, 5mm kits include STENTube(s).

  • Reduces trauma to the lacrimal system
  • Eliminates placement of tubes in patients
  • High success rate
  • Simultaneous bilateral inflation reduces O.R. and anesthesia time

The LacriCATH balloon catheters are used in a similar manner as ordinary probing with the added benefit of an expandable balloon. The catheter also provides more options to patients who have been told only an incisional DCR surgery will solve their blocked tear duct and chronic tearing problem. Our patented design of balloon catheters allows surgeons to achieve highly-effective results while reducing the post-operative trauma patients may experience. Quest ophthalmic products are easy to use and provide a cost-effective treatment of chronic epiphora in both pediatric and adult patients.